<DOC>
	<DOCNO>NCT00954590</DOCNO>
	<brief_summary>The purpose study determine Dimebon safe effective patient moderate severe Alzheimer 's disease .</brief_summary>
	<brief_title>A Safety Efficacy Study Evaluating Dimebon ( Latrepirdine ) Patients With Moderate Severe Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>ModeratetoSevere Alzheimer 's disease MiniMental State Examination ( MMSE ) Score 5 14 , inclusive Stable donepezil least 6 month Other cause dementia Major structural brain disease Unstable medical condition significant hepatic renal disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>